1. FDA Updates on Valsartan Recalls;U.S. Food and Drug Administration,2018
2. Recall of NDMA-contaminated pseudogeneric valsartan; best generics finally no better than others?;Leclerc;Can. J. Cardiol.,2018
3. European Pharmacopoeia;Council of Europe,2018
4. United States Pharmacopoeia- USP 41 NF36;The United States pharmacopeial convention,2018
5. F. Bracher, P. Heisig, P. Langguth, E. Mutschler, G. Rücker, T. Schirmeister, G.K.E. Scriba, E. Stahl-Biskup, R. Troschütz, Arzneibuch-Kommentar, 1. Aufl. inkl. 58. Akt.lfg ed., Wissenschaftliche Verlagsgesellschaft Stuttgart, 2018.